Szpital Kliniczny Im. Karola Jonschera Uniwersytetu Medycznego Im. Karola Marcinkowskiego W Poznaniu

At Szpital Kliniczny Im. Karola Jonschera Uniwersytetu Medycznego Im. Karola Marcinkowskiego w Poznaniu, clinical trials in hematology and oncology focus strongly on childhood leukemias and related blood cancers. The studies are designed to improve treatment effectiveness, reduce relapse risk, and lower serious treatment-related complications in young patients.

• Acute lymphoblastic leukemia and lymphoblastic lymphoma research aimed at improving survival and reducing relapse
• Acute myeloid leukemia studies in children, including difficult-to-treat genetic subtypes
• Myeloid leukemia in children with Down syndrome and other high-risk pediatric blood cancers
• Testing new treatment combinations and immunotherapy approaches to improve disease control

This research reflects a broad effort to refine pediatric cancer care while supporting safer, more effective therapy for children and adolescents.

The site’s transplantology program includes trials centered on hematopoietic stem cell transplantation for children with leukemia. These studies aim to optimize transplant outcomes, preserve anti-leukemia benefit, and reduce complications such as graft-versus-host disease.

• HSCT strategies for pediatric ALL and related high-risk disease
• Approaches to reduce transplant-related toxicity while maintaining treatment benefit
• Studies of supportive therapies after transplantation to help prevent relapse
• Evaluation of transplant safety and long-term outcomes in young patients

The transplantation research at this pediatric center in Poznan is closely linked to international efforts to improve outcomes for children needing advanced blood cancer treatment.

Clinical research in neoplasms also covers pediatric solid tumors, especially liver cancers. These trials explore better treatment planning, outcome improvement, and biological sample collection to support future personalized care.

• Hepatoblastoma and hepatocellular carcinoma studies in children
• Comparing treatment approaches for different risk groups
• Evaluating whether less intensive care can maintain good outcomes in selected patients
• Collecting data to improve understanding of tumor biology and treatment toxicity

These trials help advance pediatric cancer care by balancing cure rates with long-term safety.

The research portfolio includes digestive system diseases and hemic and lymphatic diseases, with additional work in nutritional and metabolic diseases. Trials in this area focus on inflammatory conditions affecting the kidneys and gastrointestinal tract, aiming to improve symptom control and reduce harmful inflammation.

• IgA nephropathy and proteinuria management in children
• Crohn's disease affecting the esophagus, stomach, and duodenum
• Testing therapies intended to lessen inflammation and protect organ function
• Evaluating whether treatment can improve disease control compared with standard care

These studies support better management of chronic pediatric inflammatory disease through more targeted treatment options.

The site also conducts trials in respiratory tract diseases, especially pulmonary arterial hypertension in children. Research in this area aims to assess safety, effectiveness, and longer-term treatment benefit for a serious condition that affects blood flow in the lungs.

• Pediatric pulmonary arterial hypertension and related vascular disease
• Evaluating medication performance in children with chronic lung circulation problems
• Studying whether treatment can improve function and disease stability
• Long-term follow-up of therapy use in pediatric patients

This work broadens the clinical research profile of the pediatric department beyond oncology and transplant care.

Research at this hospital also includes pathological conditions, signs and symptoms and selected chronic diseases that affect quality of life in children. These trials aim to improve prevention, symptom management, and early disease control in everyday pediatric care.

• Chemotherapy-induced nausea and vomiting prevention in children receiving cancer treatment
• Hemophilia studies focused on bleeding prevention and treatment effectiveness
• Type 1 diabetes trials exploring ways to slow loss of insulin-producing cells
• Evaluating supportive therapies that can make treatment safer and more tolerable

These studies show a strong interest in both disease-specific therapy and supportive care that helps children cope better with complex illnesses.